Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
daiichi sankyo her2 | 1.76 | 1 | 9062 | 9 | 19 |
daiichi | 0.43 | 0.7 | 5189 | 79 | 7 |
sankyo | 0.43 | 0.6 | 3044 | 51 | 6 |
her2 | 1.48 | 0.4 | 9300 | 51 | 4 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
daiichi sankyo her2 dxd study in cynomolgus | 0.13 | 0.1 | 3048 | 45 |
daiichi sankyo her2 breast cancer | 0.09 | 0.5 | 6571 | 8 |
her3-dxd daiichi sankyo | 1.66 | 0.3 | 4175 | 55 |
daiichi sankyo breast cancer drug | 0.41 | 0.1 | 8801 | 51 |
daiichi sankyo lung cancer | 1.77 | 1 | 3945 | 44 |
daiichi sankyo lung cancer drug | 1.76 | 0.3 | 861 | 47 |
daiichi sankyo oncology drugs | 1.1 | 0.1 | 1170 | 74 |
daiichi sankyo and merck | 1.51 | 0.5 | 6922 | 6 |
daiichi sankyo oncology products | 1.34 | 0.6 | 1999 | 61 |
daiichi sankyo medical information | 0.08 | 0.3 | 5573 | 75 |
daiichi sankyo oncology france | 0.53 | 0.7 | 4725 | 16 |
daiichi sankyo oncology pipeline | 0.33 | 0.1 | 1368 | 31 |
astrazeneca and daiichi sankyo | 0.91 | 0.2 | 4038 | 52 |
jan burke in daiichi sankyo | 1.9 | 0.6 | 4646 | 42 |
daiichi sankyo ranbaxy case study | 0.68 | 1 | 9244 | 66 |
daiichi sankyo employee reviews | 0.04 | 0.3 | 1578 | 74 |
clinical safety scientist daiichi sankyo | 1.26 | 0.2 | 4887 | 49 |
what is daiichi sankyo | 1.87 | 0.3 | 1570 | 20 |
daiichi sankyo biotech vaccine | 0.89 | 0.2 | 9266 | 36 |
daiichi sankyo q2 2023 | 0.86 | 0.3 | 5432 | 67 |
daiichi sankyo companion diagnostics | 1.22 | 1 | 6702 | 36 |